106 related articles for article (PubMed ID: 7800347)
1. Genetic analysis of the arylamine N-acetyltransferase polymorphism in breast cancer patients.
Agúndez JA; Ladero JM; Olivera M; Abildúa R; Román JM; Benítez J
Oncology; 1995; 52(1):7-11. PubMed ID: 7800347
[TBL] [Abstract][Full Text] [Related]
2. Molecular analysis of the arylamine N-acetyltransferase polymorphism in a Spanish population.
Agúndez JA; Martínez C; Olivera M; Ledesma MC; Ladero JM; Benítez J
Clin Pharmacol Ther; 1994 Aug; 56(2):202-9. PubMed ID: 8062497
[TBL] [Abstract][Full Text] [Related]
3. Determination and allelic allocation of seven nucleotide transitions within the arylamine N-acetyltransferase gene in the Polish population.
Mrozikiewicz PM; Cascorbi I; Brockmöller J; Roots I
Clin Pharmacol Ther; 1996 Apr; 59(4):376-82. PubMed ID: 8612380
[TBL] [Abstract][Full Text] [Related]
4. Lung cancer and mutations at the polymorphic NAT2 gene locus.
Martínez C; Agúndez JA; Olivera M; Martín R; Ladero JM; Benítez J
Pharmacogenetics; 1995 Aug; 5(4):207-14. PubMed ID: 8528267
[TBL] [Abstract][Full Text] [Related]
5. Lack of association between arylamine N-acetyltransferase 2 (NAT2) polymorphism and systemic sclerosis.
Skretkowicz K; Skretkowicz J; Gawrońska-Szklarz B; Górnik W; Rychlik-Sych M; Sysa-Jedrzejowska A
Eur J Clin Pharmacol; 2005 Jan; 60(11):773-8. PubMed ID: 15565348
[TBL] [Abstract][Full Text] [Related]
6. Combined effect of CYP1B1 codon 432 polymorphism and N-acetyltransferase 2 slow acetylator phenotypes in relation to breast cancer in the Turkish population.
Ozbek YK; Oztürk T; Tüzüner BM; Calay Z; Ilvan S; Seyhan FM; Kisakesen HI; Oztürk O; Isbir T
Anticancer Res; 2010 Jul; 30(7):2885-9. PubMed ID: 20683028
[TBL] [Abstract][Full Text] [Related]
7. N-Acetyltransferase-2 genetic polymorphism, well-done meat intake, and breast cancer risk among postmenopausal women.
Deitz AC; Zheng W; Leff MA; Gross M; Wen WQ; Doll MA; Xiao GH; Folsom AR; Hein DW
Cancer Epidemiol Biomarkers Prev; 2000 Sep; 9(9):905-10. PubMed ID: 11008907
[TBL] [Abstract][Full Text] [Related]
8. N-acetyltransferase (NAT2) polymorphism and breast cancer susceptibility: a lack of association in a case-control study of Turkish population.
Kocabaş NA; Sardaş S; Cholerton S; Daly AK; Karakaya AE
Int J Toxicol; 2004; 23(1):25-31. PubMed ID: 15162844
[TBL] [Abstract][Full Text] [Related]
9. Association between N-acetyltransferase 2 (NAT2) genetic polymorphism and development of breast cancer in post-menopausal Chinese women in Taiwan, an area of great increase in breast cancer incidence.
Huang CS; Chern HD; Shen CY; Hsu SM; Chang KJ
Int J Cancer; 1999 Jul; 82(2):175-9. PubMed ID: 10389748
[TBL] [Abstract][Full Text] [Related]
10. NAT2 slow acetylator genotype as an important modifier of breast cancer risk.
Sillanpää P; Hirvonen A; Kataja V; Eskelinen M; Kosma VM; Uusitupa M; Vainio H; Mitrunen K
Int J Cancer; 2005 Apr; 114(4):579-84. PubMed ID: 15609332
[TBL] [Abstract][Full Text] [Related]
11. Identification and prevalence study of 17 allelic variants of the human NAT2 gene in a white population.
Agúndez JA; Olivera M; Martínez C; Ladero JM; Benítez J
Pharmacogenetics; 1996 Oct; 6(5):423-8. PubMed ID: 8946474
[TBL] [Abstract][Full Text] [Related]
12. Arylamine N-acetyltransferase 2 slow acetylator polymorphisms in unrelated Iranian individuals.
Bakayev VV; Mohammadi F; Bahadori M; Sheikholslami M; Javeri A; Masjedi MR; Velayati AA
Eur J Clin Pharmacol; 2004 Sep; 60(7):467-71. PubMed ID: 15316701
[TBL] [Abstract][Full Text] [Related]
13. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.
Okkels H; Sigsgaard T; Wolf H; Autrup H
Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426
[TBL] [Abstract][Full Text] [Related]
14. Slow acetylator mutations in the human polymorphic N-acetyltransferase gene in 786 Asians, blacks, Hispanics, and whites: application to metabolic epidemiology.
Lin HJ; Han CY; Lin BK; Hardy S
Am J Hum Genet; 1993 Apr; 52(4):827-34. PubMed ID: 8460648
[TBL] [Abstract][Full Text] [Related]
15. Human acetylator genotype: relationship to colorectal cancer incidence and arylamine N-acetyltransferase expression in colon cytosol.
Rodriguez JW; Kirlin WG; Ferguson RJ; Doll MA; Gray K; Rustan TD; Lee ME; Kemp K; Urso P; Hein DW
Arch Toxicol; 1993; 67(7):445-52. PubMed ID: 7902079
[TBL] [Abstract][Full Text] [Related]
16. N-acetyltransferase 2 (NAT2) polymorphism in patients with atopic asthma.
Pawlik A; Juzyszyn Z; Gawronska-Szklarz B
Arch Med Res; 2009 May; 40(4):264-7. PubMed ID: 19608015
[TBL] [Abstract][Full Text] [Related]
17. The arylamine N-acetyltransferase (NAT2) polymorphism and the risk of adverse reactions to co-trimoxazole in children.
Zielińska E; Niewiarowski W; Bodalski J
Eur J Clin Pharmacol; 1998; 54(9-10):779-85. PubMed ID: 9923584
[TBL] [Abstract][Full Text] [Related]
18. NAT2 gene polymorphisms in three indigenous groups in the Colombian Caribbean Coast region.
Arias I; Lecompte N; Visbal L; Curiel I; Hernández E; Garavito P; Silvera-Redondo C
Colomb Med (Cali); 2014; 45(4):148-53. PubMed ID: 25767302
[TBL] [Abstract][Full Text] [Related]
19. Ethnic distribution of slow acetylator mutations in the polymorphic N-acetyltransferase (NAT2) gene.
Lin HJ; Han CY; Lin BK; Hardy S
Pharmacogenetics; 1994 Jun; 4(3):125-34. PubMed ID: 7920692
[TBL] [Abstract][Full Text] [Related]
20. Genotype and allele frequencies of TPMT, NAT2, GST, SULT1A1 and MDR-1 in the Egyptian population.
Hamdy SI; Hiratsuka M; Narahara K; Endo N; El-Enany M; Moursi N; Ahmed MS; Mizugaki M
Br J Clin Pharmacol; 2003 Jun; 55(6):560-9. PubMed ID: 12814450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
